Invivyd, Inc. (IVVD)
2.47
+0.04
(+1.65%)
USD |
NASDAQ |
Dec 31, 16:00
2.49
+0.02
(+0.81%)
After-Hours: 20:00
Invivyd Total Liabilities (Quarterly): 46.09M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| Relmada Therapeutics, Inc. | 5.411M |
| Arcellx, Inc. | 215.14M |
| ADMA Biologics, Inc. | 137.50M |
| Cidara Therapeutics, Inc. | 96.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 139.16M |
| Shareholders Equity (Quarterly) | 93.07M |
| Debt to Equity Ratio | 0.0288 |
| Current Ratio | 2.467 |
| Net Debt Paydown Yield | -0.17% |